| Anthony Tarr, CRNA | |
|
7525 California Ave, Boardman, OH 44512-5623 | |
| (330) 758-1954 | |
| Not Available |
| Full Name | Anthony Tarr |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 7525 California Ave, Boardman, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790715944 | NPI | - | NPPES |
| 000000139899 | Other | ANTHEM | |
| 2029432 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN206014 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Tarr, CRNA Po Box 182255, Columbus, OH 43218-2255 Ph: (614) 430-5724 | Anthony Tarr, CRNA 7525 California Ave, Boardman, OH 44512-5623 Ph: (330) 758-1954 |
News Archive
Today, the U.S. Supreme Court upheld the Affordable Care Act. The following is the National Association for Home Care & Hospice's (NAHC) official statement, from President Val J. Halamandaris:
The Pittcon Program Committee is extremely pleased to announce that Dr. Karl Deisseroth, the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University, and Investigator of the Howard Hughes Medical Institute, will deliver the Wallace H. Coulter lecture at Pittcon 2017.
In releasing a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health care that the government is ignoring lead to two to three women dying daily in the United States from pregnancy-related complications, with half of these deaths believed preventable, according to the Centers for Disease Control. A state-by-state examination shows that Michigan is 42nd on a maternal mortality ranking, with 13.6 deaths per 100,000 live births.
Exelixis, Inc. today reported positive updated interim data from the cohort of hepatocellular carcinoma (HCC) patients participating in the ongoing phase 2 randomized discontinuation trial (RDT) of cabozantinib.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has submitted a protocol revision that has passed FDA review for the enrollment of the next 40 subject "mid strength" dose cohort in the dose-ranging Phase II study of ADXS-HPV, an immunotherapy for Cervical Intraepithelial Neoplasia.
› Verified 7 days ago
John J Zajac, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6505 Market St, Building B, Boardman, OH 44512 Phone: 330-758-1065 Fax: 330-286-5396 | |
Kristine Harp, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8401 Market St, Jameson Hospital, Boardman, OH 44512 Phone: 330-729-2929 | |
Maria Rolinski Cochran, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7630 Southern Blvd, Boardman, OH 44512 Phone: 330-758-1954 | |
Mrs. April L Patterson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 866 Edenridge Dr, Boardman, OH 44512 Phone: 330-518-9579 | |
Mary L Mcclure, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 7525 California Ave, Boardman, OH 44512 Phone: 330-758-1954 | |
Jenna Sammartino, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7630 Southern Blvd, Boardman, OH 44512 Phone: 330-758-1954 | |
David Buzzacco, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7525 California Ave, Boardman, OH 44512 Phone: 330-758-1954 |